25B‐NBOMe, a novel N ‐2‐methoxybenzyl‐phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential

Four Novel Synthetic Tryptamine Analogs Induce Head-Twitch Responses and Increase 5-HTR2a in the Prefrontal Cortex in Mice

(2019) Arvie Abiero et al.   Biomolecules & Therapeutics

A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents

(2019) Jee-Yeon Seo et al.   BRAIN RESEARCH BULLETIN

A new synthetic drug 5-(2-aminopropyl)indole (5-IT) induces rewarding effects and increases dopamine D1 receptor and dopamine transporter mRNA levels

(2018) Chrislean Jun Botanas et al.   BEHAVIOURAL BRAIN RESEARCH

The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment

(2018) Xue Yang et al.   Frontiers in Molecular Neuroscience

The circadian gene, Per2 , influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice

(2018) Mikyung Kim et al.   ADDICTION BIOLOGY

5-Methoxy-α-methyltryptamine (5-MeO-AMT), a tryptamine derivative, induces head-twitch responses in mice through the activation of serotonin receptor 2a in the prefrontal cortex

(2018) Arvie Abiero et al.   BEHAVIOURAL BRAIN RESEARCH

Overexpression of the Thyroid Hormone-Responsive (THRSP) Gene in the Striatum Leads to the Development of Inattentive-like Phenotype in Mice

(2018) Raly James Perez Custodio et al.   NEUROSCIENCE

Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents

(2017) Jae Hoon Cheong et al.   PSYCHOPHARMACOLOGY

The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation

(2016) Ji-Hwan Oh et al.   ADDICTION BIOLOGY

Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal

(2016) Wenwei Ren et al.   MEDICINE

Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways

(2016) Irina N. Krasnova et al.   PSYCHOPHARMACOLOGY

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

(2015) Anna Rickli et al.   NEUROPHARMACOLOGY

NBOMe: a new dangerous drug similar to LSD

(2015) Lysa Remy et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe

(2014) M. H. Y. Tang et al.   CLINICAL TOXICOLOGY

25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers

(2014) Ioannis Papoutsis et al.   Forensic Toxicology

Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case series

(2013) Simon L. Hill et al.   CLINICAL TOXICOLOGY

Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36

(2013) Anders Ettrup et al.   MOLECULAR IMAGING AND BIOLOGY

CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat

(2013) Irina N. Krasnova et al.   NEUROBIOLOGY OF DISEASE

Characterization of the head-twitch response induced by hallucinogens in mice

(2013) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

(2013) Amy J. Eshleman et al.   PSYCHOPHARMACOLOGY

Mechanisms of dopamine transporter regulation in normal and disease states

(2013) Roxanne A. Vaughan et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal

(2012) Pao-Huan Chen et al.   ADDICTION BIOLOGY

Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist–benzodiazepine combination, zoletil

(2012) June Bryan I. de la Peña et al.   BEHAVIOURAL PHARMACOLOGY

Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease

(2012) Robert B. White et al.   CNS & Neurological Disorders-Drug Targets

Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model

(2012) Clint E. Canal et al.   Drug Testing and Analysis

Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens

(2012) Joshua T. Morra et al.   NEUROPHARMACOLOGY

Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats

(2012) Tomáš Páleníček et al.   PSYCHOPHARMACOLOGY

Transcriptional Mechanisms of Drug Addiction

(2012) Eric J. Nestler   Clinical Psychopharmacology and Neuroscience

Addiction Circuitry in the Human Brain

(2011) Nora D. Volkow et al.   Annual Review of Pharmacology and Toxicology

ΔFosB Enhances the Rewarding Effects of Cocaine While Reducing the Pro-Depressive Effects of the Kappa-Opioid Receptor Agonist U50488

(2011) John W. Muschamp et al.   BIOLOGICAL PSYCHIATRY

Transcriptional and epigenetic mechanisms of addiction

(2011) Alfred J. Robison et al.   NATURE REVIEWS NEUROSCIENCE

EEG delta oscillations as a correlate of basic homeostatic and motivational processes

(2011) Gennady G. Knyazev   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice

(2010) Adam L Halberstadt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Twenty-five years of quantitative PCR for gene expression analysis

(2008) Heather D. VanGuilder et al.   BIOTECHNIQUES